ArticleApplied health economics and health policy2021

Cost-Utility Analysis of Dapagliflozin Versus Saxagliptin Treatment as Monotherapy or Combination Therapy as Add-on to Metformin for Treating Type 2 Diabetes Mellitus.

Shanshan Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.